During the 2011 Horn of Africa famine, UNICEF estimated that over 320,000 children in Somalia alone were acutely malnourished, with global acute malnutrition (GAM) rates in some districts of Bakool and Lower Shabelle exceeding 30 per cent - well above the emergency threshold of 15 per cent. That crisis, and the recurrent food emergencies of the Sahel that have followed each year since, have forced a sustained reckoning with how the international health community defines, identifies, and treats child wasting. This article reviews the clinical and epidemiological dimensions of wasting, distinguishes it from the longer shadow cast by stunting, and examines the evidence base for community-based management of acute malnutrition (CMAM) as the dominant treatment model across Sub-Saharan Africa.

What Is Wasting? The WHO Definition and Anthropometric Thresholds

Wasting refers to the loss or failure to gain weight relative to height, and is the principal indicator of acute undernutrition in children under five years of age. The WHO defines wasting as a weight-for-height z-score (WHZ) below −2 standard deviations from the median of the WHO Child Growth Standards, established using the MGRS (Multicentre Growth Reference Study) cohort data published between 2006 and 2011 ( de Onis et al., 2011 ). Severe acute malnutrition (SAM) is defined as WHZ below −3 SD or the presence of bilateral pitting oedema, while moderate acute malnutrition (MAM) falls between −3 and −2 SD.

Mid-upper arm circumference (MUAC) has become an operationally preferred screening tool, particularly in resource-constrained field settings. A MUAC below 115 mm in children aged 6–59 months indicates SAM; a MUAC between 115 and 124 mm indicates MAM. MUAC is favoured because it requires only a colour-coded tape measure, can be administered by community health workers with minimal training, and has been shown to predict mortality risk independently of WHZ ( Bhutta et al., 2013 ). The two measures are not interchangeable: they identify overlapping but distinct populations, and debate persists over which criterion should trigger therapeutic feeding enrolment. Some national programmes now use MUAC alone as the admission criterion, while others retain both.

The bilateral pitting oedema criterion captures a different pathophysiological syndrome. Kwashiorkor - the oedematous form of severe malnutrition - can coexist with apparently adequate weight-for-height, meaning a child meeting the WHZ criterion for moderate rather than severe wasting can nonetheless be at extreme metabolic risk if oedema is present. For a fuller treatment of the clinical distinction between kwashiorkor and marasmus, including the hormonal and protein-deficiency mechanisms implicated in oedema formation, see Kwashiorkor and Marasmus: Clinical Features, Pathophysiology, and Management .

Wasting vs Stunting: A Crucial Distinction

Wasting and stunting are both products of undernutrition, but their time frames, causes, and consequences differ materially. Stunting - defined as height-for-age z-score below −2 SD - reflects chronic or recurrent nutritional insult accumulating over months or years, typically from conception through the first 1,000 days. Wasting, by contrast, is acute: it can develop within weeks of dietary inadequacy, infection, or displacement.

The epidemiological pattern differs accordingly. Stunting prevalences change slowly across populations and respond to generational improvements in diet, sanitation, and maternal education. Wasting rates fluctuate with seasonal food availability, with prevalences in the Sahel and Horn of Africa often doubling during the pre-harvest “lean season” months. A child can be both wasted and stunted simultaneously - a condition sometimes termed “double burden of undernutrition at the individual level” - and such children face compounded mortality risk.

Black et al. (2013) , in the second Lancet Nutrition Series, estimated that globally wasting contributes to approximately 800,000 under-five deaths annually, while stunting and other forms of undernutrition together account for 45 per cent of all child mortality. The causal pathways differ: wasting kills primarily through metabolic failure, immune compromise, and infection susceptibility in the short term, whereas stunting exerts its damage across the life course through impaired neurodevelopment, reduced lean mass, and increased risk of non-communicable disease in adult life. These distinctions are explored further in Stunting in Children: Definition, Causes, and Long-Term Consequences .

Epidemiological Burden in Sub-Saharan Africa

UNICEF, WHO, and the World Bank publish joint estimates of child malnutrition every two years. The 2023 joint estimates placed the number of wasted children globally at approximately 45 million, with Sub-Saharan Africa and South Asia together accounting for the vast majority. In SSA, national prevalence rates vary enormously: from under 3 per cent in several southern African countries to over 15 per cent in Chad, Mali, Niger, and South Sudan - countries where chronic food insecurity, conflict, poor water and sanitation, and high infectious disease burdens converge.

The relationship between infection and wasting is bidirectional and reinforcing. Diarrhoeal disease, respiratory infections, and malaria each accelerate nutrient losses and suppress appetite; acutely malnourished children mount weaker immune responses and are at greater risk of invasive bacterial infections ( Guerrant et al., 2008 ). Early-life enteric infections, even subclinical ones, appear to impair gut mucosal function persistently - a phenomenon described as environmental enteric dysfunction (EED) - reducing absorptive capacity and contributing to both wasting and stunting trajectories. This entero-nutritional cycle is one reason why nutrition interventions alone are insufficient in contexts of poor water and sanitation infrastructure.

Mortality risk associated with SAM is among the highest of any paediatric condition in low-income countries. A meta-analysis by Pelletier and colleagues estimated that even mild-to-moderate undernutrition potentiates the mortality risk of common infections substantially, with malnourished children dying from illnesses that better-nourished children routinely survive ( Pelletier et al., 1995 ). The relative risk of death among children with WHZ below −3 SD is estimated at 9–30 times higher than for well-nourished children, depending on the disease context. These figures underline why treatment coverage - the proportion of SAM cases reached by therapeutic services - remains a critical programme metric, and why the shift from facility-based to community-based treatment has been transformative.

Causes and Risk Factors

The proximate cause of wasting is inadequate dietary intake relative to metabolic needs, often precipitated or deepened by infection. Structural determinants operate at multiple levels: household food insecurity driven by poverty, drought, and conflict; poor maternal nutrition before and during pregnancy affecting intrauterine growth and early postnatal reserves; inadequate infant and young child feeding practices (sub-optimal breastfeeding, late complementary feeding introduction, low dietary diversity); and poor environmental health.

Prentice et al. (2013) reviewed the metabolic and epigenetic consequences of early-life undernutrition, noting that the hormonal adaptations to energy shortage - including suppression of insulin-like growth factor-1 (IGF-1), thyroid hormones, and sex steroids - compromise immune surveillance and repair mechanisms. These hormonal shifts are partly adaptive in the short term but become pathological when the deficit is sustained. The result is progressive lean tissue catabolism, micronutrient depletion, and immune paralysis.

Seasonality interacts with all these pathways. In the Sahel, wasting prevalence can rise by 5–8 percentage points between harvest and the subsequent lean season, a pattern documented across Mali, Niger, Burkina Faso, and northern Nigeria. Seasonal food insecurity also coincides with the peak malaria transmission period, amplifying the infection-undernutrition cycle at the population level.

The Clinical Spectrum: SAM and MAM

Severe acute malnutrition presents as one of two primary clinical syndromes, or a combination of both. Marasmus is characterised by severe wasting of muscle and subcutaneous fat, leading to the characteristic appearance of loose, wrinkled skin and visible skeletal prominences. Kwashiorkor is characterised by bilateral pitting oedema, skin changes, hair colour changes, and, frequently, fatty liver - arising from protein deficiency affecting albumin synthesis and free radical detoxification. Mixed marasmic-kwashiorkor presents features of both.

MAM - WHZ between −2 and −3 SD, or MUAC 115–124 mm - represents a larger population than SAM but carries meaningfully elevated mortality risk, particularly in the context of epidemic disease or food crisis. Many children cycle between MAM and wasting without ever reaching SAM criteria, accumulating growth deficits over repeated episodes.

The treatment approach differs by severity. Children with SAM and medical complications - including severe anaemia, hypoglycaemia, hypothermia, or dehydration - require inpatient stabilisation. Those with uncomplicated SAM can be managed at community level using ready-to-use therapeutic food (RUTF).

Therapeutic Feeding: From Centres to Communities

For most of the 20th century, treatment of severe acute malnutrition required admission to therapeutic feeding centres (TFCs), where children received supervised dietary rehabilitation using milk-based therapeutic diets (F-75 for stabilisation, F-100 for catch-up growth), alongside treatment of infections and electrolyte imbalances. This model produced good outcomes under optimal conditions but was fundamentally limited in reach: facilities were concentrated in urban areas or district hospitals; families in remote communities could not access them; and TFC capacity was rapidly overwhelmed during acute food crises.

The key transformation came with the development and scale-up of ready-to-use therapeutic food - a high-energy, lipid-based paste formulated from peanuts, milk powder, vegetable oil, sugar, and micronutrient fortification, with a water activity too low to support bacterial growth and therefore safe for home use without refrigeration. The landmark paper by Collins et al. (2006) described the CMAM approach, demonstrating in programme data from Malawi, Ethiopia, and Sudan that community-based treatment of uncomplicated SAM with RUTF achieved recovery rates of 75–80 per cent, mortality rates below 5 per cent, and default rates substantially lower than TFCs - because treatment was administered at home, removing the need for mothers to leave fields, other children, and livelihoods for weeks at a time.

The CMAM Protocol in Practice

CMAM - community-based management of acute malnutrition - operates as an integrated four-component system:

Community mobilisation and outreach: Community health workers and volunteers screen children using MUAC tapes, often during scheduled community growth monitoring or immunisation events. Early identification is critical because morbidity and default rates increase with severity at admission.

Outpatient therapeutic programme (OTP): Children with uncomplicated SAM are enrolled in OTP, receiving a weekly or bi-weekly RUTF ration calculated at approximately 200 kcal/kg/day. Mothers return weekly for weight monitoring and morbidity screening. A standard RUTF sachet (92 g) provides 500 kcal; most children receive 3–4 sachets daily depending on weight. Amoxicillin is provided routinely as prophylactic antibiotic coverage, along with vitamin A supplementation.

Stabilisation centre (SC): Children with SAM plus complications - typically anorexia (tested using the RUTF appetite test), oedema grade +++, or signs of systemic infection - are referred to inpatient SCs for WHO Phase 1 stabilisation using F-75 milk formula, followed by transition to RUTF and discharge to OTP once stabilised.

Supplementary feeding programme (SFP): Children with MAM receive supplementary food rations (typically a RUSF - ready-to-use supplementary food - or fortified blended food such as Plumpy’Sup or Super Cereal Plus) to support recovery without escalating to therapeutic feeding.

Manary & Sandige (2008) reviewed the evidence base for RUTF specifically in the context of community-based treatment, concluding that home-based therapy with RUTF is at least as effective as inpatient milk-based therapy for uncomplicated SAM, with major operational advantages in scale and coverage. The nutrient composition of standard RUTF meets WHO specifications for a complete therapeutic diet, including essential fatty acids, zinc, iron, and vitamins A, B-complex, C, D, and E.

Evidence on CMAM Effectiveness

The evidence base for CMAM has expanded substantially since the Collins et al. 2006 publication. Programme evaluations from Niger, Ethiopia, South Sudan, Democratic Republic of Congo, and Nigeria consistently report recovery rates of 70–85 per cent when coverage is adequate and supply chains are functional. Meta-analyses and systematic reviews confirm that community-based models achieve comparable or superior outcomes to facility-based models for uncomplicated cases while treating vastly larger numbers.

Bhutta et al. (2013) , in the second Lancet Nutrition Series, modelled the impact of scaling up nutrition-specific interventions - including management of SAM - to 90 per cent coverage in the 34 highest-burden countries. They estimated that SAM management scale-up alone could prevent approximately 435,000 deaths annually, making it one of the highest-impact single interventions available. The cost per child treated ranges from approximately USD 150 to USD 350 depending on country context, commodity logistics, and programme modality - a favourable cost-effectiveness profile relative to most paediatric interventions in LMICs.

Coverage surveys using the semi-quantitative evaluation of access and coverage (SQUEAC) methodology routinely reveal that even well-resourced national CMAM programmes reach only 20–40 per cent of SAM cases. Barriers include geographic distance, opportunity costs to caregivers, low community awareness, and stock-outs of RUTF. These data suggest that the primary bottleneck in reducing wasting mortality is not the efficacy of the treatment protocol but the coverage of that protocol in practice. For a discussion of the data infrastructure needed to monitor coverage and health system performance over time, see Implementing Health and Demographic Surveillance Systems .

Integrating CMAM with Broader Nutrition Programming

CMAM does not operate in isolation. Effective programmes link OTP exit to supplementary feeding to prevent relapse; integrate with malaria treatment, vaccination, and WASH programming to address the entero-nutritional cycle; and connect to social protection schemes that address the food insecurity driving wasting in the first place. Programme evidence from Niger’s experience of integrating CMAM with blanket supplementary feeding during the lean season suggests that preventive supplementation may reduce SAM incidence, though randomised evidence on optimal approaches to prevention versus treatment allocation remains limited.

The role of micronutrient deficiencies in the aetiology and recovery trajectory of acute malnutrition deserves emphasis. Zinc deficiency specifically impairs immune function and gut mucosal integrity, accelerating infection-driven wasting. Refeeding with RUTF corrects multiple micronutrient deficits simultaneously, but the specific contributions of individual nutrients to recovery are difficult to disentangle in field conditions.

Limitations

Several important limitations bear on the evidence reviewed here. First, most CMAM programme data come from programme reports or retrospective cohort designs rather than randomised controlled trials; external validity is uncertain when programmes are implemented outside controlled research conditions. Second, standard admission and discharge criteria (WHZ and MUAC) were derived from populations in which both measures were available; the increasing adoption of MUAC-only protocols may select for different sub-populations with different prognoses. Third, long-term outcomes of children treated for SAM - including neurodevelopmental outcomes, catch-up growth trajectories, and risk of relapse - are poorly characterised, as most programme monitoring extends only to discharge. Fourth, the cost-effectiveness estimates reviewed here are sensitive to assumptions about commodity pricing and health system overhead costs, and may not generalise to fragile or conflict-affected settings where supply chain costs are substantially higher.

FAQ

What is the clinical definition of wasting in children? Wasting is defined by the WHO as a weight-for-height z-score (WHZ) below −2 standard deviations from the median of the WHO Child Growth Standards, or by a MUAC below 125 mm (severe: below 115 mm). Bilateral pitting oedema also triggers a severe malnutrition diagnosis regardless of WHZ. Severe acute malnutrition (SAM) corresponds to WHZ below −3 SD or MUAC below 115 mm.

How does wasting differ from stunting? Wasting reflects acute, recent nutrient deficiency or illness and can develop within weeks. Stunting reflects chronic undernutrition over months or years, resulting in low height-for-age. Stunting typically does not reverse even when acute nutrition improves; wasting can resolve rapidly with appropriate treatment. A child can be both wasted and stunted, compounding mortality and developmental risk.

What is RUTF and why is it used for treating SAM at home? Ready-to-use therapeutic food (RUTF) is a lipid-based, high-energy, micronutrient-fortified paste - typically peanut-based - formulated specifically for the rehabilitation of severely malnourished children. Its low water activity prevents microbial contamination, making it safe for home storage and use without refrigeration. This property enables community-based treatment: mothers can administer daily rations at home without hospital admission, dramatically expanding treatment coverage.

What coverage rates do CMAM programmes typically achieve? Coverage surveys in SSA typically find that CMAM programmes reach 20–40 per cent of SAM cases at any given time, even in well-resourced national programmes. Geographic remoteness, caregiver opportunity costs, supply chain disruptions, and low community awareness are the most frequently cited barriers. Several countries, including Niger and South Sudan, have demonstrated that community health worker-led active case-finding can substantially increase coverage, though sustaining this requires dedicated financing and community engagement.

Dr. Amara Osei is a research fellow in global health nutrition. This article is part of an academic archive on nutrition in Sub-Saharan Africa.